Mark A. Smith
2020
In 2020, Mark A. Smith earned a total compensation of $596.8K as Chief Medical Officer at Vistagen Therapeutics, a 4% decrease compared to previous year.
Compensation breakdown
| Option Awards | $179,988 |
|---|---|
| Salary | $416,850 |
| Total | $596,838 |
Smith received $416.9K in salary, accounting for 70% of the total pay in 2020.
Smith also received $180K in option awards.
Rankings
In 2020, Mark A. Smith's compensation ranked 10,528th out of 13,090 executives tracked by ExecPay. In other words, Smith earned more than 19.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,528 out of 13,090 | 20th |
Division Manufacturing | 4,516 out of 5,618 | 20th |
Major group Chemicals And Allied Products | 1,876 out of 2,251 | 17th |
Industry group Drugs | 1,642 out of 1,951 | 16th |
Industry Pharmaceutical Preparations | 1,213 out of 1,456 | 17th |
Source: SEC filing on July 27, 2020.
Smith's colleagues
We found four more compensation records of executives who worked with Mark A. Smith at Vistagen Therapeutics in 2020.